Literature DB >> 34914042

Revisiting the Principles of Designing a Vaccine.

Shubhranshu Zutshi1, Sunil Kumar1, Prashant Chauhan1, Bhaskar Saha2,3.   

Abstract

Immune principles formulated by Jenner, Pasteur, and early immunologists served as fundamental propositions for vaccine discovery against many dreadful pathogens. However, decisive success in the form of an efficacious vaccine still eludes for diseases such as tuberculosis, leishmaniasis, and trypanosomiasis. Several antileishmanial vaccine trials have been undertaken in past decades incorporating live, attenuated, killed, or subunit vaccination, but the goal remains unmet. In light of the above facts, we have to reassess the principles of vaccination by dissecting factors associated with the hosts' immune response. This chapter discusses the pathogen-associated perturbations at various junctures during the generation of the immune response which inhibits antigenic processing, presentation, or remodels memory T cell repertoire. This can lead to ineffective priming or inappropriate activation of memory T cells during challenge infection. Thus, despite a protective primary response, vaccine failure can occur due to altered immune environments in the presence of pathogens.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antigen priming; Epitope crypticity; Immune synapse; Leishmania; Proteomics; Reverse vaccinology; Subcellular localization; T cell plasticity; Vaccine

Mesh:

Substances:

Year:  2022        PMID: 34914042     DOI: 10.1007/978-1-0716-1884-4_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  169 in total

1.  Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.

Authors:  P C Melby; J Yang; W Zhao; L E Perez; J Cheng
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Principles of Vaccination.

Authors:  Fred Zepp
Journal:  Methods Mol Biol       Date:  2016

3.  A combined proteomic and transcriptomic approach to the study of stage differentiation in Leishmania infantum.

Authors:  François McNicoll; Jolyne Drummelsmith; Michaela Müller; Eric Madore; Nathalie Boilard; Marc Ouellette; Barbara Papadopoulou
Journal:  Proteomics       Date:  2006-06       Impact factor: 3.984

Review 4.  Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives.

Authors:  Ana Paula Fernandes; Eduardo Antonio Ferraz Coelho; George Luiz Lins Machado-Coelho; Gabriel Grimaldi; Ricardo Tostes Gazzinelli
Journal:  Curr Opin Microbiol       Date:  2012-06-13       Impact factor: 7.934

Review 5.  Key concepts in immunology.

Authors:  Muriel Moser; Oberdan Leo
Journal:  Vaccine       Date:  2010-08-31       Impact factor: 3.641

6.  Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection.

Authors:  D McMahon-Pratt; D Rodriguez; J R Rodriguez; Y Zhang; K Manson; C Bergman; L Rivas; J F Rodriguez; K L Lohman; N H Ruddle
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

Review 7.  Vaccine candidates against leishmania under current research.

Authors:  Salvador Iborra; José Carlos Solana; José María Requena; Manuel Soto
Journal:  Expert Rev Vaccines       Date:  2018-04-10       Impact factor: 5.217

8.  gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani.

Authors:  Swati Bhowmick; Rajesh Ravindran; Nahid Ali
Journal:  Infect Immun       Date:  2008-01-14       Impact factor: 3.441

9.  Quantitative proteomic profiling of the promastigotes and the intracellular amastigotes of Leishmania donovani isolates identifies novel proteins having a role in Leishmania differentiation and intracellular survival.

Authors:  Neha Biyani; Rentala Madhubala
Journal:  Biochim Biophys Acta       Date:  2012-07-28

10.  Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major.

Authors:  S Gurunathan; D L Sacks; D R Brown; S L Reiner; H Charest; N Glaichenhaus; R A Seder
Journal:  J Exp Med       Date:  1997-10-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.